Lamotrigine

Product NDC: 0115-9940
Requested package NDC: 0115-9940-08
11-digit product format: 001159940
Labeler code: 0115
Product ID: 0115-9940_813e9f35-df9e-428a-9f4f-1a312c86f937
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: LAMOTRIGINE
Dosage form: TABLET, ORALLY DISINTEGRATING
Route: ORAL
Labeler: Amneal Pharmaceuticals of New York LLC
Application: ANDA200828
Marketing category: ANDA
Marketing start: 2018-12-27
Substance: LAMOTRIGINE
Active strength: 50 mg/1
Pharmacologic classes: Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 4 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	`1332a3947898…`	`d4bfe170f9cd…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A200828-001	LAMOTRIGINE	LAMOTRIGINE	25MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15
A200828-002	LAMOTRIGINE	LAMOTRIGINE	50MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15
A200828-003	LAMOTRIGINE	LAMOTRIGINE	100MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15
A200828-004	LAMOTRIGINE	LAMOTRIGINE	200MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-product	TE code
A200828-001	AB
A200828-002	AB
A200828-003	AB
A200828-004	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 164 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A200828-001	LAMOTRIGINE	25MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A200828-002	LAMOTRIGINE	50MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A200828-003	LAMOTRIGINE	100MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A200828-004	LAMOTRIGINE	200MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A200828-001	LAMOTRIGINE	25MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A200828-002	LAMOTRIGINE	50MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A200828-003	LAMOTRIGINE	100MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A200828-004	LAMOTRIGINE	200MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A200828-001	LAMOTRIGINE	25MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A200828-002	LAMOTRIGINE	50MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A200828-003	LAMOTRIGINE	100MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A200828-004	LAMOTRIGINE	200MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A200828-001	LAMOTRIGINE	25MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A200828-002	LAMOTRIGINE	50MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A200828-003	LAMOTRIGINE	100MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A200828-004	LAMOTRIGINE	200MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A200828-001	LAMOTRIGINE	25MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A200828-002	LAMOTRIGINE	50MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A200828-003	LAMOTRIGINE	100MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A200828-004	LAMOTRIGINE	200MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A200828-001	LAMOTRIGINE	25MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A200828-002	LAMOTRIGINE	50MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A200828-003	LAMOTRIGINE	100MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A200828-004	LAMOTRIGINE	200MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A200828-001	LAMOTRIGINE	25MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A200828-002	LAMOTRIGINE	50MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A200828-003	LAMOTRIGINE	100MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A200828-004	LAMOTRIGINE	200MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A200828-001	LAMOTRIGINE	25MG	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-15	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A200828-002	LAMOTRIGINE	50MG	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-15	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A200828-003	LAMOTRIGINE	100MG	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-15	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A200828-004	LAMOTRIGINE	200MG	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-15	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A200828-001	LAMOTRIGINE	25MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A200828-002	LAMOTRIGINE	50MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A200828-003	LAMOTRIGINE	100MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A200828-004	LAMOTRIGINE	200MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A200828-001	LAMOTRIGINE	25MG	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-15	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A200828-002	LAMOTRIGINE	50MG	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-15	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A200828-003	LAMOTRIGINE	100MG	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-15	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A200828-004	LAMOTRIGINE	200MG	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-15	`d06236e962d9…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 88 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A200828-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A200828-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A200828-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A200828-004	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A200828-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A200828-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A200828-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A200828-004	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A200828-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A200828-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A200828-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A200828-004	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A200828-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A200828-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A200828-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A200828-004	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A200828-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A200828-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A200828-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A200828-004	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A200828-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A200828-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A200828-003	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A200828-004	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A200828-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A200828-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A200828-003	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A200828-004	AB	1	`2680178bc6a6…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A200828-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A200828-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A200828-003	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A200828-004	AB	1	`d8e5a09893c0…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A200828-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A200828-002	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A200828-003	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A200828-004	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A200828-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A200828-002	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A200828-003	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A200828-004	AB	1	`5d02ea3f76ae…`

Additional Listing Data#

Finished product: Yes
Brand name base: Lamotrigine
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
LAMOTRIGINE	50 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
U3H27498KS	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
103968	Internal RxNorm lookup
198430	Internal RxNorm lookup
252478	Internal RxNorm lookup
252479	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
9e5c2d76-47a6-4a57-b23c-2398b307380c	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
14a9502b-3d70-0496-a7e1-b16edaa005b8	Product name	5	20250423
16d731ed-ff3e-e9a1-3e3e-1ef6b6be40a0	Product name	7	20250401
e29d8e8b-4bc8-ebaf-f18e-e35287b19d6a	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

Effective, Related label table
Effective	Related label
2024-09-19	These highlights do not include all the information needed to use LAMOTRIGINE ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE ORALLY DISINTEGRATING TABLETS. LAMOTRIGINE orally disintegrating tablets, for oral use Initial U.S. Approval: 1994
2023-01-30	These highlights do not include all the information needed to use LAMOTRIGINE ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE ORALLY DISINTEGRATING TABLETS. LAMOTRIGINE orally disintegrating tablets, for oral use Initial U.S. Approval: 1994
2020-11-24	These highlights do not include all the information needed to use LAMOTRIGINE ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE ORALLY DISINTEGRATING TABLETS. LAMOTRIGINE orally disintegrating tablets, for oral use Initial U.S. Approval: 1994
2020-09-27	These highlights do not include all the information needed to use LAMOTRIGINE ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE ORALLY DISINTEGRATING TABLETS. LAMOTRIGINE orally disintegrating tablets, for oral use Initial U.S. Approval: 1994
2020-09-25	These highlights do not include all the information needed to use LAMOTRIGINE ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE ORALLY DISINTEGRATING TABLETS. LAMOTRIGINE orally disintegrating tablets, for oral use Initial U.S. Approval: 1994
2020-07-22	These highlights do not include all the information needed to use LAMOTRIGINE ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE ORALLY DISINTEGRATING TABLETS. LAMOTRIGINE orally disintegrating tablets, for oral use Initial U.S. Approval: 1994

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0115-9940-01	Lamotrigine	30 in 1 BOTTLE	TABLET, ORALLY DISINTEGRATING	30		14

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0115-9940-01	EA - Each	0115-9940	3db0dd87-ab92-41bc-957b-5e79d55a80ac	1	2025-02-10
0115-9940-08	EA - Each	0115-9940	79061c35-9a03-4c11-a2e3-47617dab91a4	1	2019-05-02
0115-9940-68	EA - Each	0115-9940	06e88c61-69b4-4cdd-ba16-426fbc6fe480	1	2019-05-02

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0115-9940	LAMOTRIGINE TABLET, ORALLY DISINTEGRATING [AMNEAL PHARMACEUTICALS OF NEW YORK LLC]	12	Current NDC, Legacy NDC, 1 package rows	20241024_9e5c2d76-47a6-4a57-b23c-2398b307380c.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Lamotrigine	LAMOTRIGINE	Amneal Pharmaceuticals of New York LLC	9e5c2d76-47a6-4a57-b23c-2398b307380c	2025-12-04	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 200828 application number: ANDA200828 ndc (product): 0115-9940
Lamotrigine	LAMOTRIGINE	Amneal Pharmaceuticals of New York LLC	380bddae-5b31-4965-96de-97711d859d11	2016-02-02	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 200828 application number: ANDA200828

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
U3H27498KS	LAMOTRIGINE	84057-84-1	LAMOTRIGINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
103968	lamoTRIgine 100 MG Disintegrating Oral Tablet	PSN	9e5c2d76-47a6-4a57-b23c-2398b307380c	14
252479	lamoTRIgine 200 MG Disintegrating Oral Tablet	PSN	9e5c2d76-47a6-4a57-b23c-2398b307380c	14
198430	lamoTRIgine 25 MG Disintegrating Oral Tablet	PSN	9e5c2d76-47a6-4a57-b23c-2398b307380c	14
252478	lamoTRIgine 50 MG Disintegrating Oral Tablet	PSN	9e5c2d76-47a6-4a57-b23c-2398b307380c	14
103968	lamotrigine 100 MG Disintegrating Oral Tablet	SCD	9e5c2d76-47a6-4a57-b23c-2398b307380c	14
252479	lamotrigine 200 MG Disintegrating Oral Tablet	SCD	9e5c2d76-47a6-4a57-b23c-2398b307380c	14
198430	lamotrigine 25 MG Disintegrating Oral Tablet	SCD	9e5c2d76-47a6-4a57-b23c-2398b307380c	14
252478	lamotrigine 50 MG Disintegrating Oral Tablet	SCD	9e5c2d76-47a6-4a57-b23c-2398b307380c	14

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0115-9940-08	00115994008	2 BLISTER PACK in 1 CARTON (0115-9940-08) > 15 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (0115-9940-68)	2 blister pack	2018-12-27	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Lamotrigine	Amneal Pharmaceuticals of New York LLC \| Amneal Pharmaceuticals Private Limited	2025-12-04	HUMAN PRESCRIPTION DRUG LABEL	14